Spots Global Cancer Trial Database for Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Prognostic and Predictive Markers of Response to Treatment in Patients With Bile Duct Cancer: ACABi PRONOBIL Study
Official Title: Marqueurs Pronostiques et prédictifs de réponse Aux Traitements Chez Les Patients Atteints de Cancer Des Voies Biliaires : Cohorte Multicentrique ACABi PRONOBIL
Study ID: NCT04935853
Conditions
Interventions
Study Description
Brief Summary: The objective of this study is to identify prognosis and predictive markers of response to treatments (surgery, chemotherapy, targeted therapy,loco-regional treatments ) in patients with bile duct cancer. The effectiveness and tolerance of these treatments in current practice will also be evaluated.
Detailed Description: Bile duct cancers are a heterogeneous group of rare tumors with a poor prognosis. Surgery is the only curative modality for localized forms. Chemotherapy is the standard treatment in advanced forms. Identification of prognostic and predictive markers to better stratify patients and to guide therapeutic decisions is a major issue. It is retro-prospective (diagnosis between 2003 and 2021) and prospective (diagnosis between 2021 and 2030) multi-center, cohort study. Follow-up for 10 years from initial cancer diagnosis will be done. Follow-up is retrospective only for patients operated on or diagnosed in the past for more than 10 years, and retro-prospective for operated patients or diagnosed in the past for less than 10 years. The data collected for each patient are available during the life cycle of this clinical trial to fulfil an educational requirement (e.g. a doctoral thesis) upon request and authorization from the study committee and the study sponsor (GERCOR).
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
CHU Hôpital Sud Amiens, Amiens, , France
CHU Angers, Angers, , France
CHU Besançon, Besançon, , France
Hôpital Avicenne, Bobigny, , France
CHU - Henri Mondor, Créteil, , France
CHU Dijon, Dijon, , France
CHU Grenoble, Grenoble, , France
CHU Lille, Lille, , France
Centre Léon Bérard, Lyon, , France
Hôpital Croix Rousse, Lyon, , France
Hôpital Edouard Herriot, Lyon, , France
Hôpital Privé Jean Mermoz, Lyon, , France
Institut Paoli Calmette, Marseille, , France
CHU Saint Eloi Montpellier, Montpellier, , France
CHU Nantes, Nantes, , France
Centre Antoine Lacassagne, Nice, , France
CHR Orléans, Orléans, , France
Groupe Hospitalier Pitié Salpêtrière, Paris, , France
Hôpital Ambroise Paré, Paris, , France
Hôpital Cochin, Paris, , France
Hôpital Saint Antoine, Paris, , France
Hôpital Saint Louis, Paris, , France
Institut Mutualiste Montsouris, Paris, , France
Hôpital Haut Lévêque, Pessac, , France
CHU Poitiers, Potiers, , France
Hôpital Robert Debré -CHU Reims, Reims, , France
Centre Eugène Marquis, Rennes, , France
CHU Rouen Charles Nicolle, Rouen, , France
Institut Curie, Saint-Cloud, , France
CHU Saint Etienne, Saint-Étienne, , France
CHU Rangueil, Toulouse, , France
CHU Tours, Tours, , France
CHRU Nancy Site Brabois, Vandœuvre-lès-Nancy, , France
Institut Gustave Roussy, Villejuif, , France
Contact Details
Name: Cindy Neuzillet, Dr
Affiliation: Institut Curie, Saint-Cloud
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
